Gary D. Gentzkow
Technik-/Wissenschafts-/F&E-Leiter bei Theregen, Inc.
Profil
Gary D.
Gentzkow is currently the Chief Medical Officer at Theregen, Inc. and Excaliard Pharmaceuticals, Inc. He previously worked as the Medical Director at Advanced Tissue Sciences, Inc., Chief Medical Officer at TGI Holdings, Inc., and Principal at Smith + Nephew, Inc. Gentzkow received his undergraduate degree from Harvard University and his doctorate from Oregon Health & Science University.
Aktive Positionen von Gary D. Gentzkow
Unternehmen | Position | Beginn |
---|---|---|
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 06.08.2009 |
Ehemalige bekannte Positionen von Gary D. Gentzkow
Unternehmen | Position | Ende |
---|---|---|
Smith + Nephew, Inc.
Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
Advanced Tissue Sciences, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
TGI Holdings, Inc. /Hawaii/
TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Gary D. Gentzkow
Harvard University | Undergraduate Degree |
Oregon Health & Science University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
TGI Holdings, Inc. /Hawaii/
TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Health Technology |
Theregen, Inc.
Theregen, Inc. Miscellaneous Commercial ServicesCommercial Services Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA. | Commercial Services |
Smith + Nephew, Inc.
Smith + Nephew, Inc. Medical SpecialtiesHealth Technology Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN. | Health Technology |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Advanced Tissue Sciences, Inc. | Commercial Services |